Curriculum Vitae

Scopus ID: 7006633082

Prof Viola was born in Padua. He graduated in Pharmacy (1988) and Chemistry and Pharmaceutical technology at the University of Padua. He started his career as researcher at FIDIA Research Laboratories and then joined the University of Padua as research assistant. He spent a large number of periods with qualified research structures abroad. Actually, he is Associate Professor at the University of Padua in the Department of Woman’s and Child’s Health (UOC of Oncohematology). Since 2017 he has got the Italian Scientific National Habilitation to Full Professor of Medicinal Chemistry. His research interests concern the study of new molecules endowed with antiproliferative activity both in vitro and in vivo and in particular of the mechanisms that lead to cell death. In the last years his research efforts have been devoted to the identification of new targets in childhood acute lymphoblastic leukemia and in pediatric brain cancers with particular attention on drug resistance. He is author of more than 160 scientific paper in qualified peer review journals (H index=36, 8879 citations). It is responsible of the unit of the University of PADOVA in the context of SUMCASTEC project-Horizon 2020 that deal with a development of a medical device able to separate cancer stem cells in medulloblastoma and glioblastoma through the application of electromagnetic fields. Moreover, is also granted in the last three years by AIRC (Investigator Grant), Fondazione JUST and participate as team members in several projects (Cariparo pediatrico, Rally Foundation, Ministerio de Innovación y Ciencia, Spain). He currently serves as reviewer for many journals in the field of medicinal chemistry and pharmacology and he is Associate editor of Biochemical Pharmacology and editorial board member of Cancers. He is holder of many patents concerning the synthesis and antitumor application of new potential antitumoral molecules.


Semiconductor-based Ultrawideband Micromanipulation of CAncer STEm Cells

This project has received funding from the European Union’s Horizon 2020 Framework Programme FET OPEN Research and innovation under grant agreement N° 737164

Latest pubblications: Click here

Related Laboratories

Experimental Pharmacology

The laboratory is interested in design and development of new potential antitumor drugs and in study of transcriptional factors involved in genesis of leukaemia.